- Home
- GPCR vs OMCL Comparison
GPCR vs OMCL Comparison
Compare GPCR & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- OMCL
- Stock Information
- Founded
- GPCR 2016
- OMCL 1992
- Country
- GPCR United States
- OMCL United States
- Employees
- GPCR N/A
- OMCL N/A
- Industry
- GPCR
- OMCL Computer Manufacturing
- Sector
- GPCR
- OMCL Technology
- Exchange
- GPCR Nasdaq
- OMCL Nasdaq
- Market Cap
- GPCR 1.2B
- OMCL 1.4B
- IPO Year
- GPCR 2023
- OMCL 2001
- Fundamental
- Price
- GPCR $27.28
- OMCL $30.95
- Analyst Decision
- GPCR Strong Buy
- OMCL Buy
- Analyst Count
- GPCR 8
- OMCL 7
- Target Price
- GPCR $69.57
- OMCL $46.71
- AVG Volume (30 Days)
- GPCR 1.0M
- OMCL 480.0K
- Earning Date
- GPCR 11-12-2025
- OMCL 10-29-2025
- Dividend Yield
- GPCR N/A
- OMCL N/A
- EPS Growth
- GPCR N/A
- OMCL N/A
- EPS
- GPCR N/A
- OMCL 0.49
- Revenue
- GPCR N/A
- OMCL $1,149,529,000.00
- Revenue This Year
- GPCR N/A
- OMCL $5.46
- Revenue Next Year
- GPCR N/A
- OMCL $3.75
- P/E Ratio
- GPCR N/A
- OMCL $62.80
- Revenue Growth
- GPCR N/A
- OMCL 6.39
- 52 Week Low
- GPCR $13.22
- OMCL $22.66
- 52 Week High
- GPCR $43.46
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- GPCR 68.40
- OMCL 48.02
- Support Level
- GPCR $25.65
- OMCL $29.43
- Resistance Level
- GPCR $28.12
- OMCL $31.18
- Average True Range (ATR)
- GPCR 1.60
- OMCL 0.91
- MACD
- GPCR 0.28
- OMCL -0.15
- Stochastic Oscillator
- GPCR 89.60
- OMCL 45.10
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.